Literature DB >> 26276668

Autophagic vesicles on mature human reticulocytes explain phosphatidylserine-positive red cells in sickle cell disease.

Tosti J Mankelow1, Rebecca E Griffiths1, Sara Trompeter2, Joanna F Flatt1, Nicola M Cogan1, Edwin J Massey1, David J Anstee1.   

Abstract

During maturation to an erythrocyte, a reticulocyte must eliminate any residual organelles and reduce its surface area and volume. Here we show this involves a novel process whereby large, intact, inside-out phosphatidylserine (PS)-exposed autophagic vesicles are extruded. Cell surface PS is a well-characterized apoptotic signal initiating phagocytosis. In peripheral blood from patients after splenectomy or in patients with sickle cell disease (SCD), the number of circulating red cells exposing PS on their surface is elevated. We show that in these patients PS is present on the cell surface of red cells in large (∼1.4 µm) discrete areas corresponding to autophagic vesicles. The autophagic vesicles found on reticulocytes are identical to those observed on red cells from splenectomized individuals and patients with SCD. Our data suggest the increased thrombotic risk associated with splenectomy, and patients with hemoglobinopathies is a possible consequence of increased levels of circulating mature reticulocytes expressing inside-out PS-exposed autophagic vesicles because of asplenia.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26276668      PMCID: PMC4608391          DOI: 10.1182/blood-2015-04-637702

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   25.476


  21 in total

1.  Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/beta-thalassaemic patients.

Authors:  Vichai Atichartakarn; Pantep Angchaisuksiri; Katcharin Aryurachai; Supornchai Onpun; Suporn Chuncharunee; Ammarin Thakkinstian; Kanlayanee Atamasirikul
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998

2.  Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations.

Authors:  B L Wood; D F Gibson; J F Tait
Journal:  Blood       Date:  1996-09-01       Impact factor: 22.113

3.  Thrombophilia in sickle cell disease: the red cell connection.

Authors:  B N Setty; A K Rao; M J Stuart
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

4.  Membrane assembly and remodeling during reticulocyte maturation.

Authors:  J A Chasis; M Prenant; A Leung; N Mohandas
Journal:  Blood       Date:  1989-08-15       Impact factor: 22.113

5.  Monoclonal antibodies to the membrane domain of the human erythrocyte anion transport protein. Localization of the C-terminus of the protein to the cytoplasmic side of the red cell membrane and distribution of the protein in some human tissues.

Authors:  S D Wainwright; M J Tanner; G E Martin; J E Yendle; C Holmes
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

6.  A Japanese family with two sisters apparently homozygous for Mk.

Authors:  Y Okubo; G L Daniels; S F Parsons; D J Anstee; H Yamaguchi; T Tomita; T Seno
Journal:  Vox Sang       Date:  1988       Impact factor: 2.144

7.  Reticulocyte motility and form: studies on maturation and classification.

Authors:  H C Mel; M Prenant; N Mohandas
Journal:  Blood       Date:  1977-06       Impact factor: 22.113

8.  Autophagic vacuoles in human red cells.

Authors:  G Kent; O T Minick; F I Volini; E Orfei
Journal:  Am J Pathol       Date:  1966-05       Impact factor: 4.307

9.  Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V.

Authors:  F A Kuypers; R A Lewis; M Hua; M A Schott; D Discher; J D Ernst; B H Lubin
Journal:  Blood       Date:  1996-02-01       Impact factor: 22.113

10.  Monoclonal antibodies to human erythrocytes.

Authors:  D J Anstee; P A Edwards
Journal:  Eur J Immunol       Date:  1982-03       Impact factor: 5.532

View more
  25 in total

1.  Comparison of the Proteome of Adult and Cord Erythroid Cells, and Changes in the Proteome Following Reticulocyte Maturation.

Authors:  Marieangela C Wilson; Kongtana Trakarnsanga; Kate J Heesom; Nicola Cogan; Carole Green; Ashley M Toye; Steve F Parsons; David J Anstee; Jan Frayne
Journal:  Mol Cell Proteomics       Date:  2016-03-22       Impact factor: 5.911

2.  The heart in sickle cell disease, a model for heart failure with preserved ejection fraction.

Authors:  John C Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-10       Impact factor: 11.205

3.  Abstract Book: ISEV2017.

Authors: 
Journal:  J Extracell Vesicles       Date:  2017-05-15

Review 4.  Extracellular vesicles are the Trojan horses of viral infection.

Authors:  Nihal Altan-Bonnet
Journal:  Curr Opin Microbiol       Date:  2016-05-24       Impact factor: 7.934

Review 5.  Not all red cells sickle the same: Contributions of the reticulocyte to disease pathology in sickle cell anemia.

Authors:  Marcus A Carden; Ross M Fasano; Emily Riehm Meier
Journal:  Blood Rev       Date:  2019-11-05       Impact factor: 8.250

Review 6.  Lipid Tales of Viral Replication and Transmission.

Authors:  Nihal Altan-Bonnet
Journal:  Trends Cell Biol       Date:  2016-11-09       Impact factor: 20.808

7.  Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease.

Authors:  Ramasamy Jagadeeswaran; Benjamin A Vazquez; Muthusamy Thiruppathi; Balaji B Ganesh; Vinzon Ibanez; Shuaiying Cui; James D Engel; Alan M Diamond; Robert E Molokie; Joseph DeSimone; Donald Lavelle; Angela Rivers
Journal:  Exp Hematol       Date:  2017-02-24       Impact factor: 3.084

8.  The ratio of ATP11C/PLSCR1 mRNA transcripts has clinical significance in sickle cell anemia.

Authors:  Diego A Pereira-Martins; Juan L Coelho-Silva; Igor F Domingos; Isabel Weinhäuser; Pedro L Franca-Neto; Aderson S Araujo; Rafael F Franca; Marcos A Bezerra; Antonio R Lucena-Araujo
Journal:  Ann Hematol       Date:  2021-10-14       Impact factor: 3.673

Review 9.  Therapeutic strategies for sickle cell disease: towards a multi-agent approach.

Authors:  Marilyn J Telen; Punam Malik; Gregory M Vercellotti
Journal:  Nat Rev Drug Discov       Date:  2019-02       Impact factor: 84.694

10.  mTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease.

Authors:  Jintao Wang; Jennifer Tran; Hui Wang; Chiao Guo; David Harro; Andrew D Campbell; Daniel T Eitzman
Journal:  Br J Haematol       Date:  2016-03-31       Impact factor: 8.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.